You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Is There a Correlation Between Sleep and Myocardial Infarction Incidence?

  • Authors: CME Author: Marlene Busko; News Author: Charles P. Vega, MD
  • CME / ABIM MOC / CE Released: 3/31/2023
  • Valid for credit through: 3/31/2024
Start Activity

  • Credits Available

    Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.25 ABIM MOC points

    Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    Pharmacists - 0.25 Knowledge-based ACPE (0.025 CEUs)

    Physician Assistant - 0.25 AAPA hour(s) of Category I credit

    IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for primary care physicians, cardiologists, sleep medicine specialists, nurses, nurse practitioners, pharmacists, physician assistants and other clinicians who care for patients at risk for cardiovascular disease.

The goal of this activity is for learners to be better able to evaluate the relationship between disordered sleep and myocardial infarction.

Upon completion of this activity, participants will:

  • Analyze how sleep can affect the risks for obesity and insulin resistance
  • Evaluate the relationship between disordered sleep and myocardial infarction
  • Outline implications for the healthcare team


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


News Author

  • Marlene Busko

    Freelance writer, Medscape

    Disclosures

    Marlene Busko has no relevant financial relationships.

CME Author

  • Charles P. Vega, MD

    Health Sciences Clinical Professor of Family Medicine
    University of California, Irvine School of Medicine
    Irvine, California

    Disclosures

    Charles P. Vega, MD, has the following relevant financial relationships:
    Consultant or advisor for: Boehringer Ingelheim; GlaxoSmithKline; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Editor/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships

Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 credit™ into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

    College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number: JA0007105-0000-23-109-H01-P).

    Contact This Provider

  • For Physician Assistants

    Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 4/07/2024. PAs should only claim credit commensurate with the extent of their participation.

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Is There a Correlation Between Sleep and Myocardial Infarction Incidence?

Authors: CME Author: Marlene Busko; News Author: Charles P. Vega, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 3/31/2023

Valid for credit through: 3/31/2024

processing....

Clinical Context

Poor sleep has been associated with a number of poor health outcomes in terms of mental and physical health, and sleep quality certainly plays a role in obesity and insulin resistance. A previous review by Reutrakal and Van Cauter, published in the July 2018 issue of Metabolism, assessed the evidence for these relationships.[1]

Poor sleep duration is strongly associated with increased hunger and food intake. Excessive caloric intake in cases of poor sleep goes beyond simply eating more to provide energy during increased wake time. However, the effects of sleep quality on hormones such as leptin and ghrelin are less clear. Reduced sleep duration also is associated with higher degrees of insulin resistance, but sleep fragmentation alone may not affect this outcome. Finally, increases in sleep duration through behavioral change can reduce appetite and improve glucose metabolism, but the use of pharmacotherapy to aid sleep is less likely to help metabolic outcomes.

The result of the negative metabolic effects of poor sleep can be a higher rate of cardiovascular disease. However, the effects of sleep duration on the risk for myocardial infarction (MI) are inadequately quantified. The current study addresses this issue.

Study Synopsis and Perspective

Insomnia, or difficulty falling or staying asleep, was associated with a 69% greater risk of having a MI than seen among adults without insomnia, according to new research.

Those who slept 5 or fewer hours per night had the highest risk for MI, and those with both diabetes and insomnia had double the risk for MI compared with patients without these comorbidities.

The findings are from a meta-analysis of studies in more than 1 million patients, almost all of whom were without prior MI and were, on average, in their early 50s and were followed up for 9 years.

“Insomnia and ≤5 [hours] of sleep are highly associated with increased incidence of MI; an association comparable to that of other MI risk factors and as such, it should be considered as a risk factor for MI and to be incorporated into MI prevention guidelines,” the researchers conclude.

“We believe that [insomnia] should be screened and patients should be educated about the importance of sleep because nowadays insomnia is no longer a disease--sleep deprivation could also be a life choice,” Dean told a press conference before the meeting.

“Clinicians must educate the patients about the importance of sleep in maintaining a healthy heart and encourage proper sleep hygiene,” Dean reiterated in an email to theheart.org | Medscape Cardiology.

“And if a patient still has insomnia, other methods should be considered such as cognitive behavior therapy for insomnia (CBT-I).”

This study does not allow any conclusion about whether treating insomnia will reduce heart attack risk, Jennifer L. Martin, PhD, president of the American Academy of Sleep Medicine, noted in an email to theheart.org | Medscape Cardiology. Nor does it report the diversity of study participants, as insomnia is also a health equity issue, she noted, and insomnia symptoms and comorbidities were self-reported.

However, this analysis “adds to the growing evidence that poor quality or insufficient sleep is associated with poor health,” said Dr Martin, professor of medicine at UCLA’s David Geffen School of Medicine, Los Angeles, who was not involved with this research.

The study reinforces the recommendation from the American Heart Association, which includes “Get Healthy Sleep“ as one of “Life’s Essential 8“ for heart health, Dr Martin noted.

“Particularly in primary care, where disease prevention and health promotion are important, clinicians should be asking all patients about their sleep--just like they ask about diet and exercise--as a key aspect of maintaining heart health,” she said.

Advice about basic sleep hygiene advice is a first step, she noted.

When improved sleep hygiene is not enough to address chronic insomnia, the American Academy of Sleep Medicine’s clinical practice guidelines and the guidelines of the VA/Department of Defense recommend first-line treatment with CBT-I, typically offered by a sleep specialist or mental health clinician.

Similarly, the American College of Physicians suggests that sleeping pills should be reserved for short-term use in patients who may not benefit sufficiently from CBT-I.

“Studies have found that insomnia and subsequent sleep deprivation puts the body under stress,” Dean said. “This triggers cortisol release, which could accelerate atherosclerosis” and increase risk for MI.

For this analysis the researchers identified 9 observational studies, published from 1998 to 2019, with data on incident MI in adults who had insomnia.

The diagnosis of insomnia was based on International Classification of Diseases, Ninth Revision, Clinical Modification, diagnostic codes or on the Diagnostic and Statistical Manual of Mental Disorders , which defines insomnia as the presence of any of the following 3 symptoms: difficulty initiating sleep, difficulty maintaining sleep, or early morning awakening with inability to return to sleep.

Patients with sleep apnea were excluded.

The studies were in populations in China, Germany, Norway, Taiwan, United Kingdom, and United States, in 1.1 million adults aged 18 and older and 13% reported insomnia.

During follow-up, 2406 of 153,881 patients with insomnia and 12,398 of 1,030,375 patients without insomnia had an MI.

In the pooled analysis, patients with insomnia had a significantly increased risk for MI (relative risk [RR], 1.69; P<.00001), after adjusting for age, sex, diabetes, hypertension, high cholesterol, and smoking.

Sleeping 5 hours or less was associated with a greater risk for MI than sleeping 6 hours, or 7 to 8 hours, but sleeping 9 hours or more was just as harmful.

Table. Risk for MI with Different Sleep Durations

Sleep Durations (hours/night)

RR for MI

P value

≤5 vs 6

1.38

<.00001

≤5 vs 7-8

1.56

<.00001

≤5 vs ≥9

1.04

.57

6 vs 7-8

1.14

.0002

6 vs ≥9

0.75

<.00001

7-8 vs ≥9

0.67

.67

Patients who had difficulty initiating and maintaining sleep (2 symptoms of insomnia) had a 13% increased risk for MI compared with other patients (RR = 1.13; P=.003).

However, patients who had nonrestorative sleep and daytime dysfunction despite adequate sleep, which is common, did not have an increased risk for MI compared with other patients (RR = 1.06; P=.46).

Women with insomnia had a 2.24-fold greater risk for MI than other women, whereas men with insomnia had a 2.03-fold greater risk for MI than other men.

Patients with insomnia had a greater risk for MI than those without insomnia in subgroups based on patients’ age (<65 and >65 years), follow-up duration (≤5 years and >5 years), and comorbidities (diabetes, hypertension, and hyperlipidemia).

The authors have disclosed no relevant financial relationships.

Clin Cardiol. Published online February 25, 2023.

Study Highlights

  • Researchers assessed cross-sectional, case-control, and cohort studies that assessed the effects of insomnia on the risk for MI among adults. Insomnia was defined by international standards as difficulty initiating sleep, difficulty maintaining sleep, or early morning waking. Patients with apnea were not included in the current study.
  • The main study variables were sleep duration, nonrestorative sleep, and daytime dysfunction.
  • 319 studies qualified for full-text review, and 9 studies were included in the meta-analysis. A total of 153,881 patients with insomnia were compared with 1,030,375 control subjects without insomnia.
  • The overall study quality grade was high.
  • The overall RR of MI associated with insomnia was 1.69 (95% CI, 1.41-2.02).
  • The RR for MI associated with sleep duration 5 hours or less vs 6 hours was 1.38 (95% CI, 1.23-1.54). The respective RR comparing sleep duration 6 hours vs 7 to 8 hours was 1.14 (95% CI, 1.06-1.22).
  • The risk for MI was similar in the cohort with sleep duration less than 5 hours and that with 9 hours or more. Sleep duration of 6 hours was associated with a RR for MI of 0.75 (95% CI, 0.68-0.83) compared with sleep duration of 9 hours or more.
  • Adults with difficulty initiating or maintaining sleep had a RR of MI of 1.13 (95% CI, 1.04-1.23) compared with the control group.
  • However, nonrestorative sleep and daytime dysfunction because of poor sleep were not related to a higher risk for MI.
  • The risk for MI associated with insomnia was slightly higher among adults at least 65 years of age vs those younger than 65 years, as well as among adults with concomitant diabetes, hypertension, and hyperlipidemia. Insomnia conferred a similar risk for MI among women and men.

Clinical Implications

  • Clinicians should encourage patients with sleep disorders to take steps to mitigate causative factors. Poor sleep duration is strongly associated with increased hunger and food intake. However, the effects of sleep quality on hormones such as leptin and ghrelin are less clear. Individuals with sleep dysfunction might benefit from a referral to a nutritionist and holistic evaluation of causative factors.
  • The current study finds that sleep duration of 5 hours or less or 9 hours or more was associated with an increased risk for MI, as was difficulty initiating or maintaining sleep. However, nonrestorative sleep and daytime dysfunction because of poor sleep were not related to a higher risk for MI.
  • Implications for the healthcare team: The healthcare team should counsel patients that MI is a potential complication of insomnia when providing education about the importance of sleep hygiene.

 

Earn Credit

  • Print